Randomised controlled trials of ursodeoxychoric-acid therapy for primary biliary cirrhosis: A meta-analysis

Lancet

Volumn 354, Issue 9184, 1999, Pages 1053-1060

  Goulis, John ^a   Leandro, Gioacchino ^b   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; DEATH; DISEASE COURSE; DRUG EFFICACY; HUMAN; LIVER TRANSPLANTATION; MEDICAL INFORMATION; META ANALYSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033604026     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11293-X     Document Type: Article

References (39)

1. Kaplan M.M. Primary biliary cirrhosis. N Engl J Med. 316:1987;521-528.
2. Lindor K.D. Primary biliary cirrhosis: questions and promises. Ann Intern Med. 126:1997;733-735.
3. Beuers U., Boyer J.L., Paumgartner G. Urosodeoxycholic acid in cholestatis: potential mechanisms of action and therapeutic applications. Hepatology. 28:1998;1449-1453.
4. Poupon R., Chrétien Y., Poupon R.E., Ballet F., Calmus Y., Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis. Lancet. i:1987;834-836.
5. Shapiro J.M., Smith H., Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 20:1979;137-140.
6. Poupon R.E., Lindor K.D., Cauch-Dudek K., Dickson R.E., Poupon R., Heathcote J.E. Combined analysis of randomised controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 113:1997;884-890.
7. Carithers J.R.R.L., Luketic V.A., Peters M.et al. Extended follow-up of patients in the US multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterology. 110:1996;A1163. abstr.
8. Kilmurry, M.R., Heathcote, J.E., Cauch-Dudek, et al. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology, 1996, 23, 1148-1153.
9. Parés, A., Caballeria, L., Rodes, J. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind, controlled multicentric trial. J Hepatol (in press).
10. Nicolucci A., Grilli R., Alexanian A.A., Apolone G., Torri V., Liberati A. Quality, evolution, and clinical implications of randomised, controlled trials on the treatment of lung cancer: a lost opportunity for meta analysis. JAMA. 262:1989;2101-2107.
11. Robbins J., Breslow N., Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large strata limiting models. Biometrics. 42:1986;311-323.
12. Der Simonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 7:1986;177-188.
13. DiMario F., Battaglia G., Leandro G., Grasso G., Vianello F., Vigneri S. Short-term treatment of gastric ulcer: meta-analytic evaluation of blind trials. Dig Dis Sci. 41:1996;1108-1131.
14. Leuschner U., Fischer H., Kurtz W.et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 97:1989;1268-1274.
15. Hadziyannis S., Hadziyannis E.S., Makris A. A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Hepatology. 10:1989;580. abstr.
16. Poupon, R.E., Balkau, B., Eschwége, E., Poupon, R. and the UDCA-PBC Study Group. A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
17. Battezzati P.M., Podda M., Bianchi F.B.et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: preliminary analysis of a double-blind multicenter trial. J Hepatol. 17:1993;332-338.
18. Lindor K.D., Dickson R.E., Baldus W.P.et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 106:1994;1284-1290.
19. Heathcote J.E., Cauch-Dudek K., Walker V.et al. The Canadian multicenter double-blind randomised controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 19:1994;1149-1156.
20. Turner I.B., Myszor M., Mitchison H.C., Bennett M.K., Burt A.D., James O.F.W. A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol. 9:1994;162-168.
21. Combes B., Carithers R.L., Maddrey W.C.et al. A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 22:1995;759-766.
22. Vuoristo M., Farkilla M., Karnonen A.L.et al. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology. 108:1995;1470-1478.
23. Eriksson L.S., Olsson R., Glauman H.et al. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis: a Swedish multicentre, double-blind, randomised controlled study. Scand J Gastroenterol. 32:1997;179-186.
24. Hwang S.J., Chan C.Y., Lee S.D.et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis - a short term, randomised, double-blind controlled, cross-over study with long-term follow-up. J Gastroenterol Hepatol. 8:1993;217-223.
25. Poupon, R.E., Poupon, R., Balkau B, and the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1242-47.
26. Lindor K.D., Therneau T.M., Jorgensen R.A., Malinchoc M., Dickson R.E. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 110:1996;1515-1518.
27. Lindor K.D., Jorgensen R., Therneau T.M., Smith C., Mahoney D.W., Dickson E.R. Comparison of three different doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomised trial. Hepatology. 26:1997;439A.
28. Lindor K.D., Jorgensen R.A., Therneau T.M., Malinchoc M., Dickson E.R. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clinic Proc. 72:1997;1137-1140.
29. Dickson E.R., Grambsh P.M., Fleming T.R., Fischer L.D., Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 10:1989;1-7.
30. Hughes M.D., Raskino C.L., Pocock S.J., Biagini M.R., Burroughs A.K. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med. 11:1992;1731-1745.
31. Fleming T.R., DeMets D.L. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 125:1996;605-613.
32. Simko V., Shoukry M., Prego V. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary billiard cirrhosis and in chronic heaptitis. Am J Gastroenterol. 89:1994;392-398.
33. Bonnand A.M., Heathcote J.E., Lindor K., Poupon R.E. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary billiary cirrhosis. Hepatology. 29:1999;39-43.
34. Garrido M.C., Hubscher S.G. Accuracy of staging in primary biliary cirrhosis. J Clin Pathol. 49:1996;556-559.
35. Angulo P., Batts K.P., Therneau T.M., Jorgensen R.A., Dickson E.R., Lindor K.D. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology. 29:1999;644-647.
36. Degott C., Zafrani E.S., Callard P., Balkau B., Poupon R.E., Poupon R. Histopathological study of primary biliary cirrhosis and the effect of ursodexoycholic progression. Hepatology. 29:1999;1007-1012.
37. Kim R.W., Wiesner R.H., Therneau T.M.et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology. 28:1998;33-38.
38. Gluud C., Christensen E. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - A Cochrane Hepato-biliary systematic review. J Hepatol. 30:1999;83A. abstr.
39. Ursodeoxycholic acid for primary biliary cirrhosis. Drug Ther Bull. 37:1999;30-32.